Rebecca Hays, Ph.D., is a partner and intellectual property lawyer with Foley & Lardner LLP, where she is a member of the firm’s Chemical, Biotechnology & Pharmaceutical Practice.
Dr. Hays focuses on counseling clients on a wide range of technologies related to biopharmaceuticals, including oligonucleotide therapeutics such as siRNA treatment strategies.
Dr. Hays received her law degree (J.D., 2010) from the University of Minnesota Law School where she was a legal writing instructor and lead articles editor for the Minnesota Journal of Law, Science, and Technology. She was the recipient of the Stone Scholarship. Dr. Hays graduated from Northwestern University (Ph.D., molecular biology, cell biology and genetics, 1999) where she received a pre-doctoral fellowship award from the Northwestern University Lurie Cancer Center. She earned her bachelor’s degree in biology from the University of Minnesota (B.S., 1993).
After receiving her Ph.D., Dr. Hays did post-doctoral research in the Department of Molecular Biology and Pharmacology at Washington University Medical School in St. Louis. She then joined the faculty of the University of Kansas, where she was assistant professor in the Department of Molecular Biosciences and an independent investigator in cancer-related genetics.
Dr. Hays is a member of the Wisconsin Bar Association. She is admitted to practice in Wisconsin and before the United States Patent and Trademark Office.